Reuters -- Eli Lilly & Co (LLY.N) is looking for acquisitions of as much as $15 billion, the drug maker’s chief executive John Lechleiter told the Wall Street Journal in an interview.
Reuters -- Eli Lilly & Co (LLY.N) is looking for acquisitions of as much as $15 billion, the drug maker’s chief executive John Lechleiter told the Wall Street Journal in an interview.
